Literature DB >> 27518498

Periodontitis promotes the diabetic development of obese rat via miR-147 induced classical macrophage activation.

Ran Xu1, Guang Zeng2, Shuyong Wang3, Hong Tao1, Le Ren1, Zhe Zhang1, Qingna Zhang1, Jinxiu Zhao1, Jing Gao4, Daxu Li5.   

Abstract

BACKGROUND: Emerging evidence has indicated the bad effect of periodontal inflammation on diabetes control. However, the exact regulatory mechanisms within the association between periodontitis and diabetic development remain unclear. This study aims to investigate the function of microRNAs in regulating periodontitis-induced inflammation in an obese rat model.
METHODS: Experimental periodontitis was introduced into OLETF and LETO rat. Intraperitoneal glucose tolerance test was performed to detect diabetic development. Serum cytokines levels and microRNAs expression were detected by ELISA and RT-PCR analysis respectively. And, macrophages were isolated for gain- and loss-of-function studies, to investigate the regulatory mechanism of miR-147 in periodontitis-induced inflammation.
RESULTS: Periodontitis induced proinflammatory response with classical activated macrophages in both rats, but distinctively aggravated the impaired glucose tolerance of OLETF rat with spontaneous type 2 diabetes. Analysis for serum microRNAs expression showed the distinctive and synergistic upregulation of miR-147 with periodontitis-induced effects in rats, while further experiments demonstrated the positive regulatory mechanism of miR-147 on classical activated macrophages with overexpressed proinflammatory markers, showing M1 phenotype.
CONCLUSION: This study provided new evidence for the positive effect of periodontal inflammation on diabetic development, while the regulatory mechanism of miR-147 on classical macrophage activation, was verified, and presumed to contribute to the impaired glucose tolerance aggravated by periodontitis in obese rats. Besides, this study indicated the application of miR-147 for therapeutic approach in the treatment of diabetes with periodontitis.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Diabetes; M1 macrophage; Periodontitis; miR-147

Mesh:

Substances:

Year:  2016        PMID: 27518498     DOI: 10.1016/j.biopha.2016.07.030

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

Review 1.  Extracellular Vesicle/Macrophage Axis: Potential Targets for Inflammatory Disease Intervention.

Authors:  Desheng Tang; Feng Cao; Changsheng Yan; Kun Fang; Jiamin Ma; Lei Gao; Bei Sun; Gang Wang
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

Review 2.  Inflammation-Related Epigenetic Modification: The Bridge Between Immune and Metabolism in Type 2 Diabetes.

Authors:  Qiyou Ding; Zezheng Gao; Keyu Chen; Qiqi Zhang; Shiwan Hu; Linhua Zhao
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

3.  Identification of microRNAs involved in NOD-dependent induction of pro-inflammatory genes in pulmonary endothelial cells.

Authors:  Ann-Kathrin Vlacil; Evelyn Vollmeister; Wilhelm Bertrams; Florian Schoesser; Raghav Oberoi; Jutta Schuett; Harald Schuett; Sonja Huehn; Katrin Bedenbender; Bernd T Schmeck; Bernhard Schieffer; Karsten Grote
Journal:  PLoS One       Date:  2020-04-30       Impact factor: 3.240

4.  Lipoxin A4 promotes autophagy and inhibits overactivation of macrophage inflammasome activity induced by Pg LPS.

Authors:  Jie Zhao; Wenjing Geng; Kefei Wan; Kailei Guo; Fengjun Xi; Xiangqun Xu; Xiujuan Xiong; Xu Huang; Jiayi Liu; Xiaodong Kuang
Journal:  J Int Med Res       Date:  2021-02       Impact factor: 1.671

Review 5.  MiR-147: Functions and Implications in Inflammation and Diseases.

Authors:  Ling Lin; Kebin Hu
Journal:  Microrna       Date:  2021

Review 6.  Expression of MicroRNAs in Periodontal and Peri-Implant Diseases: A Systematic Review and Meta-Analysis.

Authors:  Farah Asa'ad; Carlos Garaicoa-Pazmiño; Christer Dahlin; Lena Larsson
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.